Standard Industrial Classification Code

(redirected from 5010)

Standard Industrial Classification Code

A four digit code used in business to classify the industry to which a company belongs. The SIC code was created by the U.S. government in 1937 to facilitate communication within and between businesses and industries. For the most part, the SIC was replaced by the six digit NAICS in 1997, but the SEC still uses the SIC. For example, an oil & gas exploration company might file with the SEC under the SIC code 1382.
References in periodicals archive ?
Contract notice: Flooring work for the extension and renovation of the northern tract in the chiemseehof in 5010 salzburg
The FacilityPro 5010 System is a new industrial automation solution for environmental monitoring.
html) NGC 5010 is currently transitioning from a spiral galaxy to an elliptical galaxy.
Clearinghouse honored for commitment to clients during HIPAA 5010 transition
Part of the problem, according to HHS, is that medical practices are having trouble meeting the compliance deadline for a necessary prerequisite for ICD-10, the Associated Standard Committee's X12 Version 5010 standards (Version 5010) for electronic health care transactions.
took the time to discuss the hospital's 5010 options with SSI.
Part of the problem, according to the HHS, is that medical practices are having trouble meeting the compliance deadline for a necessary prerequisite for ICD-10, the Associated Standard Committee's X12 Version 5010 standards (Version 5010) for electronic health care transactions.
Beginning January 2011, providers should begin testing Version 5010 transaction standards with their trading partners
The online directory of software vendors helps physicians determine whether the vendors' practice management systems are compliant with the 5010 standard.
com)-- Evolute has been contracted by New Directions Behavioral Health to build a solution using Microsoft BizTalk for transitioning to HIPAA 5010 as well as to enhance existing HIPAA support to include referral and approval (278) transactions in order to bring the company to HIPAA 5010 compliance.
BioLineRx (TASE:BLRX), Jerusalem, has announced the receipt of positive results from the Phase I/II clinical trial of BL- 5010, a novel formulation for the non-surgical removal of skin lesions.
An upgraded X12 Version 5010 transaction standard has been mandated for implementation by January 1, 2012 requiring significant application engineering to support future nationwide electronic healthcare interchange initiatives for the healthcare industry in the United States.